Erasca (ERAS) Long-Term Investments (2021 - 2026)
Erasca (ERAS) posted Long-Term Investments of $164.7 million for Q1 2026, up 150.63% on a QoQ basis from $65.7 million in Q4 2025, and up 54.67% year-over-year from $106.5 million in Q1 2025.
Erasca (ERAS) Long-Term Investments (2021 - 2026) Analysis & Trends
Erasca's Long-Term Investments history runs 6 years deep, the most recent figure standing at $164.7 million for Q1 2026.
- Quarterly Long-Term Investments rose 54.67% year-over-year to $164.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $164.7 million (up 54.67% YoY) and the FY2025 annual result came in at $65.7 million, down 53.77% from the prior year.
- Long-Term Investments was $164.7 million for Q1 2026 at Erasca, up from $65.7 million in the prior quarter.
- Across five years, Long-Term Investments topped out at $164.7 million in Q1 2026 and bottomed at $9.6 million in Q3 2022.
- A 5-year average of $71.3 million and a median of $58.8 million in 2024 frame the typical range for Long-Term Investments.
- Annual changes were most pronounced in 2024 — Long-Term Investments soared 1374.42% — and 2025, when it sank 53.77%.
- Erasca's Long-Term Investments stood at $9.6 million in 2022, then grew by 0.76% to $9.6 million in 2023, then surged by 1374.42% to $142.2 million in 2024, then sank by 53.77% to $65.7 million in 2025, then surged by 150.63% to $164.7 million in 2026.
- Business Quant data shows ERAS's Long-Term Investments at $164.7 million in Q1 2026, $65.7 million in Q4 2025, and $74.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 505,194.89 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 5.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.79 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Erasca | 5.89 Bn | 5.89 Bn | - | 164.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 164.72 Mn |
| Dec 31, 2025 | 65.72 Mn |
| Sep 30, 2025 | 73.98 Mn |
| Jun 30, 2025 | 86.09 Mn |
| Mar 31, 2025 | 106.50 Mn |
| Dec 31, 2024 | 142.16 Mn |
| Sep 30, 2024 | 144.39 Mn |
| Jun 30, 2024 | 51.84 Mn |
| Dec 31, 2023 | 9.64 Mn |
| Sep 30, 2023 | 46.89 Mn |
| Jun 30, 2023 | 48.08 Mn |
| Sep 30, 2022 | 9.57 Mn |
| Jun 30, 2022 | 19.31 Mn |
| Mar 31, 2022 | 29.22 Mn |
| Dec 31, 2021 | 44.77 Mn |
| Jun 30, 2021 | 5.00 Mn |